US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 24, 2018 (8 years ago)

Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

What was recalled

Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01

Recalling firm
Mylan Pharmaceuticals Inc.
NDC code
0378-7050-01
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0825-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all